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Phosphoregulation of the Titin-cap Protein Telethonin in
Cardiac Myocytes*□S
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Background: Telethonin mutations are associated with cardiomyopathy through unknown mechanisms.
Results:Telethonin is a substrate for CaMK family kinases and exists in a bis-phosphorylated state in cardiomyocytes, in which
non-phosphorylated telethonin disrupts transverse tubule organization and intracellular calcium transients.
Conclusion: Telethonin phosphorylation is critical for the maintenance of normal cardiomyocyte morphology and calcium
handling.
Significance: Disruption of phospho-telethonin functions may contribute to pathogenesis in cardiomyopathy.
Telethonin (also known as titin-cap or t-cap) is a muscle-spe-
cific proteinwhosemutation is associatedwith cardiac and skel-
etal myopathies through unknown mechanisms. Our previous
work identified cardiac telethonin as an interaction partner for
the protein kinase D catalytic domain. In this study, kinase
assays used in conjunction with MS and site-directed mutagen-
esis confirmed telethonin as a substrate for protein kinaseD and
Ca2/calmodulin-dependent kinase II in vitro and identified
Ser-157 and Ser-161 as the phosphorylation sites. Phosphate
affinity electrophoresis andMS revealed endogenous telethonin
to exist in a constitutively bis-phosphorylated form in isolated
adult rat ventricular myocytes and in mouse and rat ventricular
myocardium. Following heterologous expression in myocytes
by adenoviral gene transfer, wild-type telethonin became bis-
phosphorylated, whereas S157A/S161A telethonin remained
non-phosphorylated. Nevertheless, both proteins localized pre-
dominantly to the sarcomeric Z-disc, where they partially
replaced endogenous telethonin. Such partial replacement with
S157A/S161A telethonin disrupted transverse tubule organiza-
tion and prolonged the time to peak of the intracellular Ca2
transient and increased its variance. These data reveal, for the
first time, that cardiac telethonin is constitutively bis-phosphor-
ylated and suggest that such phosphorylation is critical for
normal telethonin function, which may include maintenance
of transverse tubule organization and intracellular Ca2
transients.
Telethonin, which is also known as titin-cap or t-cap, is a
19-kDa protein that is expressed almost exclusively in cardiac
and skeletalmuscle, with a single isoform that is encoded by the
TCAP gene and high sequence homology across species (1, 2).
The N-terminal region of telethonin forms a unique  sheet
structure in complex with the N-terminal Z1Z2 immunoglob-
ulin-like domains of two titin molecules in a palindromic
assembly, thus anchoring titin in the sarcomeric Z-disc (3, 4).
The C-terminal region (or “tail”) appears unstructured even in
complex with titin (5). A functional role for telethonin has been
implicated in sarcomere development and stability (2, 6, 7), and
mutations in TCAP are causally associated with both skeletal
(8) and cardiac (9) myopathies. It has also been proposed that
telethonin is involved in stretch sensing within the cardiac sar-
comere (10) and that itmay protect against cardiomyocyte apo-
ptosis in hearts subjected to biomechanical stress (11). How-
ever, targeted deletion of TCAP in mice produces surprisingly
subtle cardiac (11) and skeletal (12) phenotypes, suggesting that
mechanismsmore complex than loss of telethonin proteinmay
contribute to genetic telethonin myopathies.
Little is known about the posttranslational mechanisms that
may regulate telethonin function. Nevertheless, telethonin has
been shown to be an in vitro substrate for the kinase domain of
titin (titin kinase), an atypicalmember of theCa2/calmodulin-
dependent kinase (CaMK)5 family that is, in fact, not activated
by Ca2/calmodulin (13) and that phosphorylates telethonin at
a single C-terminal residue, Ser-157 (6). Furthermore, in a yeast
two-hybrid screen of a human cardiac cDNA library, we have
previously identified telethonin as an interaction partner and
potential substrate for the catalytic domain of protein kinase D
(PKD) (14), another atypical member of the CaMK family (15).
In this study, we report that telethonin is indeed a substrate for
PKD and also for CaMKII in vitro, map the phosphorylation
sites to Ser-157 and a novel C-terminal phospho-acceptor at
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Ser-161, and show, for the first time, that endogenous tele-
thonin is constitutively bis-phosphorylated in rat and mouse
myocardium. Furthermore, through partial replacement of
endogenous telethonin with a non-phosphorylatable mutant,
we provide evidence that telethonin phosphorylation may reg-
ulate transverse tubule (t-tubule) organization and the intracel-
lular Ca2 (Ca2i) transient in isolated ventricular myocytes.
These findings shed new light on the potential functions and
regulation of cardiac telethonin.
EXPERIMENTAL PROCEDURES
Detailedmethodology is provided in the supplemental mate-
rial. Methods published previously were used for key tech-
niques such as in vitro kinase assays (14), electron transfer
dissociation tandem mass spectroscopy (16), the isolation and
culture of ventricular myocytes from the adult rat heart (17),
adenoviral vector construction and myocyte infection (18),
immunoblot analysis (19), immunocytochemistry and fluores-
cence confocalmicroscopy (16, 20), and imaging and analysis of
t-tubule structure and Ca2i transients (21). Phosphate affinity
SDS-PAGE utilized polyacrylamide-bound Mn2-Phos-tag
reagent (22, 23).Quantitative data are given asmean S.E., and
intergroup comparisons were done by analysis of variance fol-
lowed by the Newman-Keuls test. p  0.05 was considered
significant.
RESULTS
Toverify our earlierwork that suggested telethonin as a puta-
tive PKD substrate, recombinant humanWT telethonin carry-
ing an N-terminal His6 tag was used in an in vitro kinase assay
with [-32P]ATP and PKDcat, a constitutively active form of the
enzyme lacking theN-terminal regulatory domain (14). 32P was
incorporated into telethonin in a time-dependent manner (Fig.
1A), confirming telethonin as an in vitro substrate for PKD. To
explore the phospho-telethonin species generated, we also ana-
lyzed PKD-mediated phosphorylation by Phos-tag phosphate
affinity SDS-PAGE in combination with immunoblot analysis
(22, 23). As the duration of the phosphorylation reaction
increased, WT telethonin was found to transition almost com-
pletely from the non-phosphorylated form to a slow-migrating,
fully phosphorylated form, with an intermediate phospho-tele-
thoninmoiety also appearing transiently during the first 10min
of the reaction and suggesting the existence of multiple PKD
phosphorylation sites (Fig. 1B). To identify the phospho-accep-
tor residues that are targeted by PKD, recombinant humanWT
telethonin was subjected to trypsin digestion following a
30-min phosphorylation in vitro by PKDcat. Analysis by nano-
flow-liquid chromatography-tandemmass spectrometry revealed
two phosphorylated residues, with characteristic neutral losses
(-49 and 98 Da) observed upon fragmentation by collision-
induced dissociation (Fig. 1C). The pertinent peptide fragment
was further analyzed by electron transfer dissociation, and the
serine residues Ser-157 and Ser-161were identified as the puta-
tive phospho-acceptor sites (Fig. 1D). To confirm that Ser-157
and Ser-161 are indeed targeted by PKD, further in vitro kinase
assays were performed, using as a substrate either WT tele-
thonin protein (as above) or amutated telethonin with replace-
ment of the putative phospho-acceptor serine residues by non-
phosphorylatable alanine, either individually or in combination
(S157A, S161A, or S157A/S161A; partial sequences are shown
in Fig. 1E). AlthoughWT telethonin proteinwas robustly phos-
phorylated by PKD, as before, the presence of each single Ser/
Ala substitution (S157A or S161A) partially attenuated such
phosphorylation (Fig. 1F). Furthermore, PKD-mediated phos-
phorylation was completely abolished by the double mutation
(S157A/S161A) (Fig. 1F). These findings show that telethonin is
phosphorylated at both Ser-157 and Ser-161 by PKD in vitro
and that no other potential phospho-acceptor residues in tele-
thonin are targeted under these conditions. Thiswas confirmed
by complementary Phos-tag phosphate affinity SDS-PAGE and
immunoblot analysis. When non-phosphorylated, WT and
mutated telethonin proteins migrated as a single band of iden-
tical mobility in a Phos-tag SDS-PAGE gel (supplemental Fig.
S1). Following PKD-mediated phosphorylation of WT, S157A,
or S161A telethonin, an additional, slower-migrating protein
band became apparent and was the predominant species in
each case (supplemental Fig. S1). Importantly, the in-gelmobil-
ity of the phospho-telethonin species varied between WT,
S157A, and S161A telethonin (supplemental Fig. S1), reflecting
the differences in the number and position of the phosphoryl-
ated serine residue(s). Furthermore, S157A/S161A mutant
telethonin, when exposed to PKD andATP likeWT telethonin,
migrated as a single band with an in-gel mobility identical to
that of non-phosphorylated S157A/S161A or WT telethonin
(supplemental Fig. S1), thus confirming the absence of addi-
tional PKD target sites other than Ser-157 and Ser-161.
We next examined the in vitro phosphorylation of telethonin
by PKD versusCa2/calmodulin-dependent kinase II (CaMKII,
 isoform) and PKA. In conditions under which PKD, CaMKII,
and PKA catalyzed comparable phosphorylation of an estab-
lished common substrate, Ser-302 of cardiac myosin-binding
protein C (cMyBP-C) (20, 24), PKD and CaMKII induced sim-
ilar phosphorylation of telethonin, indicating that both kinases
target Ser-157 and Ser-161, whereas PKA was without effect
(Fig. 2). It appears, therefore, that telethoninmay be a target for
multiple members of the CaMK family to which titin kinase,
PKD, and CaMKII all belong (but PKA does not).
The phosphorylation status of endogenous telethonin in iso-
lated adult rat ventricular myocytes (ARVM) was then investi-
gated in the absence or presence of increased cellular PKD
activity. Increased cellular PKD activity was achieved by over-
expression of WT PKD1 using an adenoviral vector (AdV:wt-
PKD) (18) and its activation by cellular stimulation with endo-
thelin 1 (ET-1) or phenylephrine (PE). Preliminary experiments
showed that ARVM infectedwithAdV:wtPKD showed increased
PKDexpression (relative to control cells infectedwithAdV:EGFP)
and that both ET-1 and PE markedly activated heterologously
expressed PKD, as reflected by its increased phosphorylation at
Ser-744/748 and Ser-916 (supplemental Fig. S2). Phos-tag SDS-
PAGE and immunoblot analysis of the same samples showed
that, in all treatment groups, endogenous telethonin migrated
as a single species whose in-gel mobility (and, therefore, phos-
phorylation status) was unaffected by increased PKD expres-
sion and activity (Fig. 3A, top panel). By reference to His6-
tagged WT telethonin included in the same gel as an internal
standard, this endogenous telethonin species migrated between
Phosphoregulation of Cardiac Telethonin
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bis-phosphorylated (pSer-157/161) and mono-phosphorylated
(pSer-161) recombinant telethonin moieties (Fig. 3A, top panel).
Importantly, standardSDS-PAGEand immunoblot analysis of the
same samples revealed that endogenous telethoninmigratesmore
rapidly than the recombinant internal standard (Fig. 3A, center
panel), most likely because of the presence of additional N-termi-
nal residues in the latter. This led us to conclude that the endoge-
nous telethonin species thatmigrates between the positions of the
FIGURE 1. PKD phosphorylates telethonin at Ser-157 and Ser-161. A, time course of PKD-mediated phosphorylation of WT telethonin. Recombinant WT
telethonin was incubated with PKDcat and [
32P]ATP and 32P incorporation over time wasmonitored by SDS-PAGE and autoradiography. Top panel, represent-
ative autoradiogramwith quantitative data below (n 4, mean S.E.). IVK, in vitro kinase. B, Phos-tag phosphate-affinity SDS-PAGE and immunoblot analysis
of PKD-mediated phosphorylation of WT telethonin showing non-phosphorylated and phosphorylated moieties (top panel). Standard SDS-PAGE and immu-
noblot (IB) analysis of the same samples is also shown (bottom panel) (n  3). C, collision-induced dissociation spectrum from the doubly charged, doubly
phosphorylated telethonin fragment peptide showing the characteristic neutral losses (-49 and98Da) of twophosphate groups from thepeptide.D, Mascot
search results obtained for electron transfer dissociation (ETD) fragmentation spectra of the doubly and triply charged precursor. S, phosphorylated serine
residue. E, schematic of telethonin, illustrating protein interactions reported previously. For interactions underscored by a dashed line, the telethonin domains
involved have not been mapped. Ankrd2, ankyrin repeat domain-containing protein 2; BMP10, bone morphogenetic protein 10; CS-1, calsarcin 1; MDM2,
murine double minute 2; MLP, muscle LIM protein. Also shown are amino acids 152–166 for all full-length recombinant telethonin proteins generated. F,
representative autoradiogram showing PKD-mediated phosphorylation of recombinant WT and mutated telethonin proteins (top panel) with quantitative
data below (n 3, mean S.E.).
Phosphoregulation of Cardiac Telethonin
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mono-phosphorylated and bis-phosphorylated recombinant
internal standards in Phos-tag SDS-PAGEgels (Fig. 3A, top panel)
is likely to represent the bis-phosphorylated form of the protein.
To confirm the identity of this predominant telethoninmoiety,we
also performed Phos-tag SDS-PAGE analysis of protein samples
extracted from uninfected ARVM in the absence of phosphatase
inhibitors with andwithout subsequent in vitro incubation with 
phosphatase (PPase). In the absence of PPase treatment, the
predominant telethonin moiety once again appeared to be bis-
phosphorylated, although additional species likely to represent
mono-phosphorylated and non-phosphorylated telethonin were
also detectable (Fig. 3B, top panel). Importantly, following PPase
treatment, only a fast-migrating species representing non-phos-
phorylated telethonin was detectable (Fig. 3B, top panel). From
this, we concluded that endogenous telethonin in isolated ARVM
is bis-phosphorylated constitutively so that its phosphorylation
status cannot be further enhanced by increased cellular PKD
activity.
To further explore the phosphorylation status of endogenous
telethonin, this was also investigated in ventricular tissue from
rat (Fig. 3C) and mouse (D) hearts. In these samples, endoge-
nous telethonin also displayed a similar migration profile (rel-
ative to the recombinant internal standard) to that observed in
isolated ARVM maintained in culture. Furthermore, PPase
treatment caused a comparable shift in the migration profile of
the predominant species. These observations suggest that
endogenous telethonin exists primarily in a constitutively bis-
phosphorylated form in isolated ARVM and in the intact rat or
mouse heart. To confirm the identity of the phosphorylated
residues in endogenous telethonin, phosphoprotein fragments
from mouse myocardium were additionally subjected to Fou-
rier transform MS analysis with high-energy collisional disso-
ciation (supplemental Fig. S3). This confirmed that endogenous
telethonin is constitutively phosphorylated at both Ser-157 and
Ser-161 in mouse myocardium in vivo (Fig. 3E).
To facilitate investigation of the functional importance of
telethonin phosphorylation, adenoviral vectors were con-
structed to allow expression of HA-tagged WT or non-phos-
phorylatable telethonin (AdV:HA-WT-telethonin and AdV:
HA-S157A/S161A-telethonin, respectively) in ARVM. SDS-
PAGE and immunoblot analysis of lysates fromARVM infected
with each adenovirus at varying multiplicities of infection
(0–1000 plague-forming units/cell) for 18 or 42 h allowed
selective detection of heterologously expressed telethonin with
an anti-HA antibody and simultaneous detection of both
endogenous and heterologously expressed telethonin with an
anti-telethonin antibody (because of slower migration of the
HA-tagged protein). Heterologous telethonin was barely
detectable 18 h post-infection (data not shown) but was
robustly expressed 42 h post-infection (supplemental Fig. S4).
A virus dose of 100 plaque-forming units/cell was selected for
both AdV:HA-WT-telethonin and AdV:HA-S157A/S161A-
telethonin for use in subsequent experiments because this pro-
duced similar levels of expression of each heterologous protein
(supplemental Fig. S4, top panel), with an abundance roughly
comparable with that of endogenous telethonin (supplemental
Fig. S4, center panel).
FIGURE 2. Telethonin is phosphorylated at Ser-157 and Ser-161 by PKD
andCaMKII but not byPKA.A, comparable phosphorylation by PKD, PKA, or
CaMKII of Ser-302 in the recombinant cardiac myosin-binding protein C
(cMyBP-C) c1c2 fragment in vitro. A recombinant His6-tagged c1c2 fragment
(100 pmol) was incubated in the presence of each kinase for 0–60 min and
subjected to immunoblot (IB) analysis using a phospho-specific pSer-302
cMyBP-C antibody. IVK, in vitro kinase. B–D, differential phosphorylation by
PKD (B), PKA (C), or CaMKII (D) of recombinant telethonin in vitro. Recombi-
nant His6-tagged WT or S157A/S161A telethonin proteins (100 pmol) were
incubated in the absence or presence of each kinase for 0, 1, or 5 min and
subjected to Phos-tag SDS-PAGE and immunoblot analysis using amonoclo-
nal anti-telethonin antibody (top panel).Arrowson the left show the identities
of dual-phosphorylated (2P),mono-phosphorylated (1P), and non-phosphor-
ylated (0P) telethonin. The bottom panel shows the same samples subjected
to standard SDS-PAGE and immunoblot analysis using the same antibody.
Phosphoregulation of Cardiac Telethonin
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We first characterized the phosphorylation status of heter-
ologously expressed, HA-tagged WT and S157A/S161A tele-
thonin in ARVM in the absence or presence of ET-1 or PE.
Phos-tag SDS-PAGE and immunoblot analysis with the
anti-HA antibody revealed a single predominant band in
ARVM expressing HA-WT-telethonin or HA-S157A/S161A-
telethonin (Fig. 4A, top panel). Importantly, however, HA-
WT-telethonin displayed markedly slower migration than
HA-S157A/S161A-telethonin (Fig. 4A, top panel), indicating
that it becomes phosphorylated following its cellular expres-
sion. With the anti-HA antibody, an additional, faster migrat-
ing moiety of lower abundance was also detected in cells
expressing HA-WT-telethonin (Fig. 4A, top panel) that likely
represents a mono-phosphorylated species. Nevertheless, no
FIGURE 3. Telethonin is constitutively phosphorylated in ventricular myocytes and tissue. A, Phos-tag SDS-PAGE and immunoblot analysis using the
monoclonal anti-telethonin antibody of samples from ARVM infected with AdV:EGFP or AdV:wtPKD and stimulated with 100 nM ET-1 or 10 M PE (with 1 M
atenolol) for 10 min. The same samples were subjected to standard SDS-PAGE and immunoblot (IB) analysis using the same antibody, and membranes were
stainedafter usewithCoomassie, as indicated. 2P, dual-phosphorylated.B, Phos-tag SDS-PAGEand immunoblot analysis using themonoclonal anti-telethonin
antibody of samples from uninfected ARVM incubated (30 min at 30 °C) in the absence (-) or presence () of PPase. The same samples were subjected to
standard SDS-PAGE and immunoblot analysis using the same antibody, and membranes were stained after use with Coomassie as indicated. 0P, non-
phosphorylated. C andD, Phos-tag SDS-PAGE and immunoblot analysis using themonoclonal anti-telethonin antibody of homogenates from rat (C) ormouse
(D) ventricular tissues from three separate hearts in each case (left panels). Data are also shown for rat (C) andmouse (D) ventricular samples incubated (30min
at 30 °C) in the absence (-) or presence () of PPase (right panels). The same samples were subjected to standard SDS-PAGE and immunoblot analysis using
the same antibody, and membranes were stained after use with Coomassie as indicated. In A–D, recombinant His6-tagged WT telethonin (100 pmol) phos-
phorylated in vitro by PKDcat for 3 min was included as an internal standard in the gels. E, summary data from Fourier transform high-energy collisional
dissociationMS sequencing of a bis-phosphorylated telethonin phosphopeptide fragment frommousemyocardium (all masses in Dalton). Amass difference
from the expectedmass of80 Da (equivalent to -PO3) is observed at both Ser-157 and Ser-161, indicating phosphorylation at these residues. aa, amino acid.
Phosphoregulation of Cardiac Telethonin
1286 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 3•JANUARY 17, 2014
 at K
IN
G
'S CO
LLEG
E LO
N
D
O
N
 on January 27, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
additional HA-tagged protein moiety became apparent in
response to stimulation of ARVM expressing HA-WT-tele-
thonin with ET-1 or PE (Fig. 4A, top panel), indicating that
the available phospho-acceptor residues in heterologously
expressedWT telethonin become fully phosphorylated by con-
stitutive kinase activity. Additionally, HA-S157A/S161A-tele-
thonin also remained as a single predominant band that
displayed markedly faster migration relative to HA-WT-tele-
thonin, regardless of stimulation with ET-1 or PE (Fig. 4A, top
panel), suggesting that signaling pathways activated by these
stimuli do not lead to phosphorylation of residues distinct from
Ser-157 and Ser-161. These findings confirm that heterolo-
gously expressed WT telethonin, like endogenous telethonin,
becomes constitutively bis-phosphorylated in ARVM, even in
the absence of neurohormonal stimulation, and that such phos-
phorylation occurs at Ser-157 and Ser-161.
When Phos-tag SDS-PAGE was followed by immunoblot
analysis with the anti-telethonin antibody (instead of the
anti-HA antibody), protein species representing endogenous
telethonin could also be visualized. Interestingly, although a
constitutively bis-phosphorylated endogenous telethonin spe-
cies was present in ARVM heterologously expressing either
HA-WT-telethonin or HA-S157A/S161A-telethonin, a non-
phosphorylated endogenous telethonin species became
apparent only in the latter group (Fig. 4A, bottom panel).
This observation suggests that the heterologous expression
of non-phosphorylatable HA-S157A/S161A-telethonin may
have an inhibitory effect on the phosphorylation of endoge-
nous telethonin, likely by acting as a pseudosubstrate inhib-
itor. In these experiments, additional analysis of the same
samples by standard SDS-PAGE and immunoblotting (with
either the anti-HA or the anti-telethonin antibody) con-
firmed that HA-WT-telethonin and HA-S157A/S161A-tele-
thonin were expressed at equivalent levels, each at an abun-
dance that was roughly comparable with that of endogenous
telethonin (Fig. 4B).
We then utilized ARVM in which heterologously expressed
HA-WT-telethonin becomes constitutively bis-phosphory-
lated, whereas HA-S157A/S161A-telethonin cannot be phos-
phorylated (Fig. 4A), to explore the potential impact of phos-
phorylation on the subcellular localization and functions of
telethonin. Immunolabelingwith theHA tag antibody and con-
focal microscopy revealed that both HA-WT-telethonin and
HA-S157A/S161A-telethonin were targeted predominantly to
the cytoplasm and concentrated at the Z-disc, where they colo-
calized with the established Z-disc marker -actinin (Fig. 5A).
Within the spatial resolution of this technique, the subcellular
localization of telethonin, therefore, does not appear to be reg-
ulated by its phosphorylation status. Endogenous telethonin is
anchored to the detergent-insoluble myofilament compart-
ment through superstable interactions of its N terminus with
theN termini of two titinmolecules at the sarcomeric Z-disc (3,
4, 25). To explore whether heterologously expressed telethonin
is able to replace endogenous telethonin in this compartment,
we performed detergent-based fractionation of ARVM pro-
teins following heterologous expression of HA-WT-telethonin
or HA-S157A/S161A-telethonin. As expected, in control cells
(infected with AdV:EGFP), endogenous telethonin resided
exclusively in the Triton-insoluble fraction (Fig. 5B, top panel).
In contrast, in ARVM infected with AdV:HA-WT-telethonin
(Fig. 5B, center panel) or AdV:HA-S157A/S161A-telethonin
(bottom panel), endogenous telethonin was detected in both
the Triton-insoluble and the Triton-soluble fractions. Further-
more, in these cells, HA-WT-telethonin or HA-S157A/S161A-
telethonin was also found in both the Triton-insoluble and the
Triton-soluble fractions (Fig. 5B), and the phosphorylation sta-
tus of each protein was comparable in either fraction (C). These
findings suggest that, when expressed at an abundance compa-
rable with that of the endogenous protein, heterologous HA-
tagged telethonin replaces a marked proportion of endogenous
telethonin in the titin-telethonin complex and that such
replacement occurs independently of the phosphorylation
FIGURE 4. Heterologously expressed WT telethonin and endogenous
telethonin are constitutively phosphorylated. A, Phos-tag SDS-PAGE and
immunoblot (IB) analysis of ARVM infected with AdV:HA-WT-telethonin or
AdV:HA-S157A/S161A-telethonin for 42 h and stimulated with vehicle, ET-1
(100 nM), or PE (10 M, with 1 M atenolol) for 10 min. Cell lysates were sub-
jected to Phos-tag SDS-PAGE and immunoblot analysis using a monoclonal
anti-HA antibody (top panel) or a monoclonal anti-telethonin antibody (bot-
tom panel). The positions of internal standards resolved in the same gel are
marked by thick black lines to the left of the immunoblot obtained with the
anti-telethonin antibody, indicating the positions of dual-phosphorylated,
mono-phosphorylated, and non-phosphorylated His6-taggedWT telethonin
from top to bottom. Arrows on the right show the deduced identities of the
indicated telethonin species. 2P-HA, dual-phosphorylated HA-tagged heter-
ologous telethonin; 1P-HA, mono-phosphorylated HA-tagged heterologous
telethonin; 0P-HA, non-phosphorylated HA-tagged heterologous telethonin;
2P, dual-phosphorylated endogenous telethonin; 0P, non-phosphorylated
endogenous telethonin. B, the same samples were subjected to standard
SDS-PAGE and immunoblot analysis using the same antibodies (n 3).
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status of the heterologously expressed telethonin. Indeed,
across multiple independent experiments, the heterologously
expressed protein represented 58  9% and 68  8% of total
telethonin in the Triton-insoluble fraction of cells infectedwith
AdV:HA-WT-telethonin or AdV:HA-S157A/S161A-telethonin,
respectively (n 10, non-significant).
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The C-terminal portion of telethonin, which contains the
phosphorylation sites that we have identified, has been shown
to interact with ion channel accessory proteins that reside in
t-tubule membranes, leading to the suggestion that telethonin
may serve as an “adapter protein” that links t-tubules to the
Z-disc complex in cardiacmyocytes (26, 27). Furthermore, tele-
thonin knockdown has been reported to interfere with t-tubule
development in striated muscle of zebrafish embryos (28), and,
recently, telethonin knockout has been shown to disrupt t-tu-
bule structure and function in mouse cardiomyocytes (29).
Therefore, we took advantage of our ability to partially replace
endogenous, phosphorylated telethonin with heterologous,
non-phosphorylatable telethonin to explore the potential role
of telethonin phosphorylation in regulating t-tubule structure
and organization in ARVM. To this end, ARVM expressing
HA-WT-telethonin or HA-S157A/S161A-telethonin were
labeled with the membrane dye di-8-ANEPPS to visualize the
t-tubule network (Fig. 6A). No differences in cell volume (Fig.
6B) or the density of the t-tubule network (C) were observed
between the two groups. However, Fourier analysis of binarized
di-8-ANEPPS-labeled images revealed significantly reduced
power of the peak corresponding to the dominant frequency of
t-tubule periodicity (used previously as an index of t-tubule
regularity (30)) in cells expressing HA-S157A/S161A-tele-
thonin relative to those expressing HA-WT-telethonin (Fig.
6D). This observation suggests that phosphorylation of tele-
thonin at Ser-157 and Ser-161may regulate the organization of
the t-tubule network so that this is disrupted by reduced phos-
phorylation. Similar Fourier analysis of the distribution of-ac-
tinin and myomesin, established markers of the Z-disc and the
M-band, following immunolabeling confirmed the absence of
general cellular disorganization and the maintenance of an
identical average sarcomere length of1.8 m on the basis of
the position of the dominant frequency (supplemental Fig. S5).
The changes in t-tubule organization that arise from partial
replacement in ARVM of endogenous, bis-phosphorylated
telethonin with heterologous, non-phosphorylatable tele-
thonin resemble those that have been reported to occur in
rodent heart failure models (30, 31) in which t-tubule remodel-
ing has been associated with abnormal Ca2i transients in iso-
lated ventricularmyocytes (27). Therefore, we also explored the
impact of partial replacement of endogenous, bis-phosphory-
lated telethonin with heterologous, non-phosphorylatable tele-
thonin on the Ca2i transient in ARVM. The dynamics and
synchronicity of the whole-cell Ca2i transient were altered in
cells expressing HA-S157A/S161A-telethonin relative to those
expressing HA-WT-telethonin (Fig. 7A). This was reflected by
a prolonged average time to peak of the Ca2i transient (Fig.
7B), despite an increase in amplitude (in units of peak/baseline
fluorescence ratio from 1.45 0.04 (n 25) to 1.72 0.07 (n
28), p 0.05), and an increased variance of time to peak of the
Ca2i transient (C). Additionally, the decay of the Ca2i tran-
sient was slowed, as reflected by increased average times to 50%
(Fig. 7D) and 90% (E) decline in cells expressing HA-S157A/
S161A-telethonin. These findings suggest that the phosphory-
lation status of telethonin may affect the synchronous release
and removal of Ca2i in time and space during excitation-con-
traction coupling, likely as a consequence of altered t-tubule
organization.
DISCUSSION
The key novel observations that arise from this study are as
follows. Ser-157 and Ser-161 in theC-terminal tail of telethonin
are substrates for theCaMK familymembers PKDandCaMKII.
These sites are maintained in a constitutively phosphorylated
state in cardiac telethonin. A genetic intervention that partially
replaces endogenous bis-phosphorylated telethonin in its
native subcellular compartment withmutated non-phosphory-
latable telethonin, but not with WT telethonin that itself
becomes bis-phosphorylated, disrupts cardiomyocyte t-tubule
organization and synchronous activation and dynamics of the
Ca2i transient. These findings provide new information on the
regulation of cardiac telethonin and the potential functional
roles of its C-terminal phosphorylation. They also raise a num-
ber of interesting questions.
Firstly, what are the mechanism(s) through which cardiac
telethonin phosphorylation is regulated? Our studies with in
vitro phosphorylation of recombinant telethonin definitively
identify Ser-157 and Ser-161 as PKD substrates. Nevertheless,
increased PKD activity in ARVM was not associated with
increased telethonin phosphorylation because the endogenous
protein existed predominantly in a constitutively bis-phos-
phorylated state, even under basal conditions. Furthermore,
telethonin phosphorylation was not reduced by incubation of
ARVMfor up to 6 hwith a bipyrydyl PKD inhibitor that exhibits
remarkable efficacy and selectivity (22) (data not shown).
Therefore, the contribution of PKD activity to the constitutive
phosphorylation of cardiac telethonin remains unclear, partic-
ularly because othermembers of the CaMK family, such as titin
kinase (6) and CaMKII (this study), can also catalyze telethonin
phosphorylation at Ser-157 alone (6) or both Ser-157 and Ser-
161, respectively. Regardless of the identity of the kinases that
catalyze telethonin phosphorylation, our findings suggest that
bis-phosphorylated telethonin has a slow turnover and may
thus be relatively resistant to dephosphorylation. This could
occur potentially because phosphorylation at Ser-157 and Ser-
161 creates a binding site for a partner protein whose associa-
tion with telethonin shields the pertinent phospho-acceptor
FIGURE 5. HA-WT-telethonin and HA-Ser-157/161-telethonin localize to the sarcomeric Z-disc and partially displace endogenous telethonin. A, con-
focal microscopy images of ARVM infected with AdV:HA-WT-telethonin or AdV:HA-S157A/S161A-telethonin for 42 h. Fixed and permeabilized cells were
immunolabeled with rat monoclonal anti-HA and mouse monoclonal anti--actinin primary antibodies and Cy3-anti-rat and Cy5-anti-mouse secondary
antibodies, and confocal microscopy was used to image infected myocytes. Cy3 (HA-telethonin) and Cy5 (-actinin) images are shown in separate channels,
with merged images showing -actinin (green), HA-telethonin (red), and nuclei stained with DAPI (blue). The line charts show the intensity plots of the Cy3
(HA-telethonin) and Cy5 (-actinin) signals over seven sarcomeres (across the regions shown by a green line on the merged images). Scale bars  10 m
(confocal images) and 2 m (intensity plots). n 4, 5 cells/experiment. B, distribution of endogenous and heterologous telethonin species in Triton-soluble
and insoluble fractions of ARVM infected with AdV:EGFP, AdV:HA-WT-telethonin, or AdV:HA-S157A/S161A-telethonin for 42 h. IB, immunoblot. C, phos-
phorylation of heterologous telethonin species in Triton-soluble and insoluble fractions of ARVM infected with AdV:EGFP, AdV:HA-WT-telethonin, or AdV:HA-
S157A/S161A-telethonin for 42 h. 2P, dual-phosphorylated; 1P,mono-phosphorylated; 0P, non-phosphorylated.
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residues from phosphatase action. To our knowledge, the only
protein that has been reported previously to interact with the
C-terminal tail of telethonin in a manner that is dependent on
the phosphorylation status of the latter is the  subunit of the
K channel that carries the slow component of the cardiac
delayed rectifier current (26). This subunit, known as minK
(also called KCNE1), was found to interact with telethonin in a
yeast two-hybrid assay, with the interaction abolished by phos-
phomimetic S157E and S157D substitutions in telethonin (26).
Nevertheless, even if a minK/telethonin interaction were to
occur in cardiomyocytes (for which there is currently no direct
evidence, especially given that minK expression is restricted to
the conduction system (32)), the indication that this interaction
is abrogated by telethonin phosphorylation at Ser-157 (26)
makes it unlikely that association with minK underlies the
apparent resistance of phospho-telethonin to phosphatase
action. Archetypal proteins that bind to phosphorylated motifs
on partner proteins are members of the 14-3-3 family, with
several recent examples that 14-3-3 binding may protect bind-
ing site phosphorylated residues from dephosphorylation (33,
34). However, by using a “far-Western” overlay assay (35), we
have found no evidence of 14-3-3 protein binding to WT or
mutated (S157A, S161A, S157A/S161A) recombinant tele-
thonin proteins in the absence or presence of PKD-mediated
phosphorylation (data not shown). Thus, at present, the cel-
lular mechanisms that are responsible for maintaining car-
diac telethonin in a constitutively bis-phosphorylated state
remain unknown. Interestingly, mono-phosphorylated and
non-phosphorylated telethonin species becamemore readily
detectable following the extraction and incubation of pro-
teins from ARVM, rat heart, and mouse heart in the absence
of phosphatase inhibitors (Fig. 3), suggesting that endoge-
FIGURE 6. Telethonin phosphorylation may regulate t-tubule organization. A, representative confocal fluorescence images of ARVM infected with AdV:
HA-WT-telethonin or AdV:HA-S157/161-telethonin for 42 h and labeled with di-8-ANEPPS. Binarized images of a central area, used for Fourier analysis of
t-tubule regularity, are also shown. B, cell volume as assessed by Z-stack analysis of confocal fluorescence images.C, density of t-tubule network as reflected by
thepercentageof the cell interior labeledwithdi-8-ANEPPS.D, Fourier analysis ofbinarizeddi-8-ANEPPS images showinga representativepower spectrum (left
panel) and quantitative data (right panel). *, p 0.05; n 25–28 cells/group.
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nous phosphatase(s) do indeed target phosphorylated Ser-
157 and Ser-161.
Secondly, what is the physiological significance of telethonin
being maintained in a constitutively bis-phosphorylated state?
Our data with partial replacement of endogenous bis-phosphor-
ylated telethoninwith heterologous non-phosphorylatable tele-
thonin in ARVM suggest that telethonin phosphorylation is
important in maintaining t-tubule organization. A possible
mechanism for such regulation of t-tubule organization is that
telethonin indeed serves as an adapter protein that anchors
t-tubules to Z-discs, as Furukawa et al. (26) have suggested, but
that phosphorylation is necessary for telethonin to serve this
function. To fulfil such an anchoring role, the phosphorylatedC
terminus of telethonin would have to interact with partner pro-
tein(s) localized to the t-tubule membrane. As noted above,
minK is a putative binding partner for telethonin and has been
reported to localize to t-tubules at the Z-disc regions of cardiac
and skeletal muscle (26). Nevertheless, as already discussed,
minK expression is restricted to the conduction system (32),
and its interaction with telethonin appears to be inhibited by
phosphomimetic substitution of the Ser-157 residue of tele-
thonin (26),makingminK an unlikely t-tubular binding partner
for the phosphorylated telethonin C terminus. Evidence sug-
gests that junctophilin 2 (JP-2), a protein of the junctophilin
family that is important for the formation of t-tubule/sarco-
plasmic reticulum junctions in cardiomyocytes (36), may also
regulate t-tubule organization (30). Consistent with this,
reduced JP-2 protein expression in cardiomyocytes by lentiviral
delivery of short hairpin RNA was found to disrupt t-tubule
organization, as reflected by a significant reduction in the
power of the dominant peak of t-tubule periodicity (30), in a
manner analogous to our observations in ARVM following het-
erologous expression of non-phosphorylatable telethonin. It is
tempting to speculate, therefore, that t-tubular JP-2 and titin-
associated telethonin may both participate in a linker complex
that anchors t-tubules to the Z-discs, thereby regulating t-tu-
bule organization. Alternatively, telethonin may modulate the
stability or function of such a complex in a phosphorylation-de-
pendent manner. Regardless of the molecular mechanisms
through which telethonin, and in particular its phosphorylated
FIGURE 7. Telethonin phosphorylationmay regulate intracellular Ca2 transients. A, representativewhole-cell Ca2i transientsmeasured in confocal line
scan mode in ARVM infected with AdV:HA-WT-telethonin or AdV:HA-S157//161A-telethonin for 42 h. ARVM were loaded with the Ca2-sensitive dye Fluo-4
and field-stimulated at 1 Hz. The quantitative data shown are the average time to peak of the Ca2i transient (B), the variance of the time to peak (C), and the
average time to 50% (D) and 90% (E) decline of the Ca2i transient. *, p 0.05; n 25–28 cells/group.
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C-terminal tail, may maintain t-tubule organization, our find-
ings suggest that this may be of functional importance in main-
taining normal Ca2i transients. In this context, the t-tubule
and Ca2i transient abnormalities that we have observed as a
result of reduced telethonin phosphorylation (through the par-
tial replacement of endogenous bis-phosphorylated telethonin
with a non-phosphorylatable variant) are similar to those that
have been reported in multiple cardiac pathologies, including
heart failure (27, 31), and, recently, in ventricular myocytes
from telethonin knockout mice (29). Ca2i transient decay is
regulated by a number of interacting factors, including the t-tu-
bular Na/Ca2 exchanger and sarcoplasmic reticular Ca2
ATPase activities. Although we have not investigated the con-
tribution of these factors to the slowed Ca2i transient decay
that we have observed in cells expressing HA-S157A/S161A-
telethonin, there is growing evidence that t-tubular disruption
impairs Ca2i extrusion via the Na/Ca2 exchanger (37).
Finally, are there potential causal roles for altered telethonin
phosphorylation in cardiac pathophysiology? At present, it is
not known whether non-phosphorylated telethonin or tele-
thonin variants that lack the phosphorylated C-terminal tail
may exist and have “poison peptide” effects that disrupt myo-
cyte function in cardiac disease. In this context, it is interesting
to note that several missense TCAPmutations associated with
human hypertrophic and dilated cardiomyopathies introduce
single residue substitutions within the C-terminal 36 amino
acids of telethonin (9), which may interfere with the phosphor-
ylation status of telethonin. Of these mutations, the potential
impact of the R153H substitution (9) is of particular interest
because of the proximity of Arg-153 to the phospho-acceptor
residues of telethonin at Ser-157 and Ser-161. It is also interest-
ing to note that TCAP mutations associated with limb-girdle
muscular dystrophy type 2G introduce premature stop codons
at the junction of exon 1 and intron 1 or in exon 2 (8). Although
immunohistochemistry and immunoblot analysis of skeletal
muscle samples from affected patients, some of whom also
exhibited heart involvement, revealed the absence of telethonin
protein, a polyclonal antibody raised against a C-terminal, 128-
amino acid telethonin fragment was used (8). Thus, expression
of truncated N-terminal telethonin fragments that lack the
phosphorylated C-terminal tail cannot be excluded (particu-
larly because TCAP has only two exons, with exon 1 coding for
amino acids 1–37). In this regard, Pinotsis et al. (5) have shown
that a truncated N-terminal telethonin fragment comprising
amino acids 1–90 can be heterologously expressed in a stable
manner (at least in neonatal rat cardiomyocytes) and that, like
the full-length protein, it localizes to the sarcomericZ-disc. The
novel findings reported in this study form a strong basis for
future work on the structural and functional roles of the C-ter-
minal tail of telethonin and its phosphorylation-regulated
interactions, particularly in the context of genetic cardiomyop-
athies associated with telethonin mutations.
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